Related Experiment Video
Updated: May 9, 2026
Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
Published on: June 28, 2024
Quantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable
Hoyoung Park1, Jong-Wook Lee, Mintai P Hwang
1Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea.
Insights
This study introduces a novel immunomagnetic assay for quantifying soluble CD40L (sCD40L), a biomarker linked to cardiovascular disease. The method effectively separates and detects sCD40L in clinically relevant ranges.
Area of Science:
- Biomarker Detection
- Cardiovascular Disease Research
- Assay Development
Background:
- Cardiovascular disease (CVD) is a leading cause of death globally.
- Soluble CD40L (sCD40L) is correlated with CVD, but quantification methods are lacking.
Purpose of the Study:
- To develop a simple immunomagnetic assay for separating and quantifying sCD40L.
- To establish a reliable method for sCD40L detection within clinically relevant ranges.
Main Methods:
- Utilized functionalized magnetic beads and detachable quantum dots.
- Employed competitive binding of imidazole and nickel ions for histidine.
- Developed a simple immunomagnetic assay for sCD40L quantification.
Main Results:
- Successfully separated and quantified sCD40L.
- Achieved detection within a clinically relevant range, including the cut-off for acute coronary disease.
- Demonstrated the assay's potential for other biomarkers.
Conclusions:
- The developed immunomagnetic assay provides an effective method for sCD40L quantification.
- This assay can aid in the diagnosis and management of cardiovascular diseases.
- The system shows promise for broader biomarker detection applications.
Abstract:
Cardiovascular disease (CVD) is a potent cause of mortality in both advanced and developing countries. While soluble CD40L (sCD40L) has been implicated as a correlative factor among CVD patients, methods to quantify sCD40L are not yet well-established. In this paper, we present an ability to separate and quantify sCD40L via a simple immunomagnetic assay. Composed of functionalized magnetic beads conferred with directionality and on-demand detachable quantum dots for subsequent optical analysis, our system utilizes the competitive nature of imidazole and nickel ions for histidine. In essence, we demonstrate the capacity to effectively separate and detect sCD40L within a clinically relevant range that contains the cut-off value for acute coronary disease. While sCD40L was used to conduct this study, we envision the use of our system for the separation and quantification of other biomarkers.
